Multiplex GPCR Assay in Reverse Transfection Cell Microarrays

G protein-coupled receptors (GPCRs) are a superfamily of proteins that include some of the most important drug targets in the pharmaceutical industry. Despite the success of this group of drugs, there remains a need to identify GPCR-targeted drugs with greater selectivity, to develop screening assays for validated targets, and to identify ligands for orphan receptors. To address these challenges, the authors have created a multiplexed GPCR assay that measures greater than 3000 receptor: ligand interactions in a single microplate. The multiplexed assay is generated by combining reverse transfection in a 96-well plate format with a calcium flux readout. This assay quantitatively measures receptor activation and inhibition and permits the determination of compound potency and selectivity for entire families of GPCRs in parallel. To expand the number of GPCR targets that may be screened in this system, receptors are cotransfected with plasmids encoding a promiscuous G protein, permitting the analysis of receptors that do not normally mobilize intracellular calcium upon activation. The authors demonstrate the utility of reverse transfection cell microarrays to GPCR-targeted drug discovery with examples of ligand selectivity screening against a panel of GPCRs as well as dose-dependent titrations of selected agonists and antagonists.

[1]  J. Chambers,et al.  A G Protein-coupled Receptor for UDP-glucose* , 2000, The Journal of Biological Chemistry.

[2]  Susan R. George,et al.  G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.

[3]  Y. Wong,et al.  Gα 16/z Chimeras Efficiently Link a Wide Range of G Protein— Coupled Receptors to Calcium Mobilization , 2003, Journal of biomolecular screening.

[4]  Ji Ming Wang,et al.  Peptide Receptor Chemotactic Agonist for Mouse Formyl Trp-Lys-Tyr-Met-Val-d-Met Is a Potent The Synthetic Peptide and , 2000 .

[5]  M. Yasutake,et al.  α1-Adrenergic Stimulation of Sarcolemmal Na+-H+ Exchanger Activity in Rat Ventricular Myocytes : Evidence for Selective Mediation by the α1A-Adrenoceptor Subtype , 1998 .

[6]  J. Wess,et al.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[7]  D. Healy,et al.  Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. , 1991, The Journal of pharmacology and experimental therapeutics.

[8]  M. Brann,et al.  Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells. , 1996, European journal of pharmacology.

[9]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[10]  R. Wurtman,et al.  Coupling of transfected muscarinic acetylcholine receptor subtypes to phospholipase D. , 1991, The Journal of biological chemistry.

[11]  Alan Wise,et al.  Target validation of G-protein coupled receptors. , 2002, Drug discovery today.

[12]  J. Kebabian,et al.  The Sigma-RBI handbook of receptor classification and signal transduction , 1995 .

[13]  Y. Wong,et al.  Incorporation of Galpha(z)-specific sequence at the carboxyl terminus increases the promiscuity of galpha(16) toward G(i)-coupled receptors. , 2000, Molecular pharmacology.

[14]  K. Ikeda,et al.  Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes. , 1998, British journal of pharmacology.

[15]  I. Hall,et al.  Effects of a range of β2 adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells , 1999 .

[16]  M. Dubocovich,et al.  Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina. , 1987, The Journal of pharmacology and experimental therapeutics.

[17]  J. Chambers,et al.  Receptor for the Pain Modulatory Neuropeptides FF and AF Is an Orphan G Protein-coupled Receptor* , 2000, The Journal of Biological Chemistry.

[18]  R. Challiss,et al.  Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle , 1995, British journal of pharmacology.

[19]  J. Debernardis,et al.  A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype. , 1995, The Journal of pharmacology and experimental therapeutics.

[20]  M. Simon,et al.  Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.

[21]  S. Rees,et al.  Chimaeric G alpha proteins: their potential use in drug discovery. , 1999, Trends in pharmacological sciences.

[22]  K. Ikeda,et al.  Effects of clozapine on the δ‐ and κ‐opioid receptors and the G‐protein‐activated K+ (GIRK) channel expressed in Xenopus oocytes , 1998 .

[23]  D. Peters,et al.  Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists. , 2006, CNS drug reviews.

[24]  Ji Ming Wang,et al.  The Synthetic Peptide Trp-Lys-Tyr-Met-Val-d-Met Is a Potent Chemotactic Agonist for Mouse Formyl Peptide Receptor1 , 2000, The Journal of Immunology.

[25]  M. Banks,et al.  An ultra-HTS process for the identification of small molecule modulators of orphan G-protein-coupled receptors. , 2003, Drug discovery today.

[26]  M. Brann,et al.  Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins. , 1997, Molecular pharmacology.

[27]  G. Zlokarnik,et al.  Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. , 1998, Science.

[28]  Prahlad T. Ram,et al.  G Protein Pathways , 2002, Science.

[29]  M. Mortrud,et al.  The G protein-coupled receptor repertoires of human and mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Sabatini,et al.  Microarrays of cells expressing defined cDNAs , 2001, Nature.

[31]  B. Conklin,et al.  Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors. , 1999, Analytical biochemistry.

[32]  F. Bymaster,et al.  Arachidonic acid release in cell lines transfected with muscarinic receptors: a simple functional assay to determine response of agonists. , 1999, Cellular signalling.

[33]  F. Bymaster,et al.  Elucidating the role of muscarinic receptors in psychosis. , 2001, Life sciences.